WallStreetZenWallStreetZen

NASDAQ: TSHA
TAYSHA GENE THERAPIES INC Stock

Buy TSHA
$3.96-0.08 (-1.98%)
Updated Jun 24, 2022
TSHA Price
$3.96
Fair Value Price
$6.49
Market Cap
$160.56M
52 Week Low
$2.33
52 Week High
$25.44
P/E
-0.78x
P/B
3.17x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$192.61M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.27
Operating Cash Flow
-$136M
Beta
1.78
Next Earnings
Aug 15, 2022
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TSHA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TSHA ($3.96) is undervalued by 38.99% relative to our estimate of its Fair Value price of $6.49 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TSHA ($3.96) is significantly undervalued by 38.99% relative to our estimate of its Fair Value price of $6.49 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
TSHA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TSHA due diligence checks available for Premium users.

TSHA News

Valuation

TSHA fair value

Fair Value of TSHA stock based on Discounted Cash Flow (DCF)
Price
$3.96
Fair Value
$6.49
Undervalued by
38.99%
TSHA ($3.96) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TSHA ($3.96) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TSHA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TSHA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.78x
Industry
-2.58x
Market
20.48x

TSHA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.17x
Industry
4.43x
TSHA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TSHA's financial health

Profit margin

Revenue
$0.0
Net Income
-$50.1M
Profit Margin
0%
TSHA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$166.0M
Liabilities
$115.3M
Debt to equity
2.27
TSHA's short-term assets ($106.89M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TSHA's short-term assets ($106.89M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TSHA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$40.8M
Investing
-$11.4M
Financing
-$242.0k
TSHA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TSHA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TSHA$160.56M-1.98%-0.78x3.17x
KMPH$160.07M+0.43%-2.55x1.32x
ORIC$162.26M-7.22%-1.86x0.64x
SPPI$158.48M-1.12%-1.02x2.87x
SESN$163.16M-0.85%3.15x0.94x

TAYSHA GENE THERAPIES Stock FAQ

What is TAYSHA GENE THERAPIES's quote symbol?

(NASDAQ: TSHA) TAYSHA GENE THERAPIES trades on the NASDAQ under the ticker symbol TSHA. TAYSHA GENE THERAPIES stock quotes can also be displayed as NASDAQ: TSHA.

What is the 52 week high and low for TAYSHA GENE THERAPIES (NASDAQ: TSHA)?

(NASDAQ: TSHA) TAYSHA GENE THERAPIES's 52-week high was $25.44, and its 52-week low was $2.33. It is currently -84.43% from its 52-week high and 69.96% from its 52-week low.

How much is TAYSHA GENE THERAPIES stock worth today?

(NASDAQ: TSHA) TAYSHA GENE THERAPIES currently has 40,546,392 outstanding shares. With TAYSHA GENE THERAPIES stock trading at $3.96 per share, the total value of TAYSHA GENE THERAPIES stock (market capitalization) is $160.56M.

TAYSHA GENE THERAPIES stock was originally listed at a price of $24.06 in Sep 24, 2020. If you had invested in TAYSHA GENE THERAPIES stock at $24.06, your return over the last 1 years would have been -83.54%, for an annualized return of -83.54% (not including any dividends or dividend reinvestments).

How much is TAYSHA GENE THERAPIES's stock price per share?

(NASDAQ: TSHA) TAYSHA GENE THERAPIES stock price per share is $3.96 today (as of Jun 24, 2022).

What is TAYSHA GENE THERAPIES's Market Cap?

(NASDAQ: TSHA) TAYSHA GENE THERAPIES's market cap is $160.56M, as of Jun 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

TAYSHA GENE THERAPIES's market cap is calculated by multiplying TSHA's current stock price of $3.96 by TSHA's total outstanding shares of 40,546,392.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.